Pharmaceutical News

RSS

Researchers discover new avenue for hypertension, cardiovascular disease treatment

More than one-third of the world's population suffers from hypertension and cardiovascular disease. The U.S. Agency for Healthcare Quality and Research has reported that Americans spent $29 billion for non-prescription cardiovascular drugs alone in 2008.

11 Apr 2011

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment

Almirall strengthens its position in the respiratory field with a positive development progress of another New Chemical Entity (NCE). LAS190792 is a new dual long-acting Muscarinic Antagonist β2 Agonist (MABA), which combines two bronchodilator mechanisms in a single molecule for the treatment of COPD.

11 Apr 2011

Immunization does not increase emergency room visit in children with inherited disorders

Children with inborn errors of metabolism received vaccines on the same immunization schedule as did healthy infants, according to Kaiser Permanente Vaccine Study Center scientists who examined the Kaiser Permanente Northern California population. In addition, immunization was not associated with significant increases in emergency room visits or hospitalizations during the month following vaccination, according to Nicola Klein, MD, PhD, lead author of the study and co-director of the Kaiser Permanente Vaccine Study Center.

11 Apr 2011

Florida Society of Pain Management Providers applauds Senate President for supporting PDMP

The Florida Society of Pain Management Providers, applauds Senate President Mike Haridopolos, Senator Mike Fasano and Attorney General Pam Bondi for their support of the Prescription Drug Monitoring Program and their united opposition to the attempt to repeal the program.

11 Apr 2011

Scientists identify new treatment to combat PFAPA syndrome in children

A preliminary study conducted by a team at the National Institutes of Health has identified a promising new treatment in children for the most common form of a rare disorder.

11 Apr 2011

IDSA, U.S. health officials describe ways to respond to global threat of antimicrobial resistance

To coincide with World Health Day on Thursday, the Infectious Diseases Society of America (IDSA) released a policy paper with nine recommendations for how to control the "ever-growing threat of antimicrobial resistance," CIDRAP News reports.

11 Apr 2011

Opinions: Budget talks, foreign aid; making drugs more accessible to poor

"If the federal government shuts down at midnight on Friday - which seems likely unless negotiations take a sudden turn toward rationality - it will not be because of disagreements over spending. It will be because Republicans are refusing to budge on these ideological demands," argues a New York Times editorial, highlighting issues such as "foreign aid to countries that might use the money for abortion or family planning ... aid to the United Nations Population Fund, which supports family-planning services."

11 Apr 2011

New weight loss pill - combination of two existing drugs

According to the latest research on obesity treatments there is now a new weapon in the battle for weight loss. It combines two existing drugs that have resulted in twice as much weight loss as the only approved long-term anti-obesity medication.

10 Apr 2011

HealthWarehouse.com implements Google Commerce Search for prescription medications

HealthWarehouse.com, Inc. a leading VIPPS accredited retail mail-order pharmacy, announced the implementation of Google's Commerce Search to help customers find prescription medications on its US website.

8 Apr 2011

Watson confirms patent challenge by Alcon for generic Vigamox

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5%. Watson's Moxifloxacin Hydrochloride Ophthalmic Solution USP, 0.5% is a generic version of Alcon, Inc.'s Vigamox®, an antibiotic solution that is indicated for the treatment of bacterial conjunctivitis.

8 Apr 2011

Impax, Banner Pharmacaps collaborate for commercialization of softgel capsule products

Impax Laboratories, Inc. today announced that it will collaborate with Banner Pharmacaps Inc. with respect to the supply and commercialization of two softgel capsule products.

8 Apr 2011

FDA accepts Antares Pharma's Anturol NDA for filing, assigns PDUFA date

Antares Pharma, Inc. today announced the New Drug Application (NDA) for Anturol® Gel in patients with overactive bladder (OAB) was accepted for filing for review by the U.S. Food and Drug Administration (FDA). Anturol is an oxybutynin gel incorporating Antares' ATD Gel technology.

8 Apr 2011

Researchers test plants used in traditional African medicine against malaria

The malaria parasite has gradually developed resistance to the most commonly used medicines. To make matters worse, several mosquito species that host and transmit the parasite have become resistant to insecticides, making it difficult to eliminate them from populated areas.

8 Apr 2011

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

NanoViricides, Inc. reports that post-infection treatment with its optimized FluCide drug candidates resulted in significant reduction in lung tissue presence of leukocytes, and in particular, that of eosinophils in a lethal influenza infection animal model.

8 Apr 2011

Lecture to explain science behind modern pharmaceutical products

The science behind the creation of medicines is the subject of a lecture at the University of Greenwich's Medway Campus on Wednesday, April 13.

8 Apr 2011

Strathclyde establishes new EPSRC Centre to improve chemical manufacturing

An EPSRC Centre for revolutionising the way pharmaceuticals and other chemicals are made is being officially launched today.

8 Apr 2011

How the pharmaceutical industry is confronting a changing landscape

News outlets report on strategies and trends regarding research and development as well as drug pricing.

8 Apr 2011

Frailty in older patients not linked to high risk of adverse drug reactions

Contrary to popular belief among physicians, frailty in elderly patients is not associated with an increased risk of adverse reactions to medications, according to a study led by Michael Steinman, MD, a geriatrician at the San Francisco VA Medical Center.

8 Apr 2011

New substance to tackle drug resistant tuberculosis

This year's World Health Day focuses on the growing threat of potentially deadly infections developing resistance to antimicrobial drugs - especially to antibiotics. On this occasion, the European Commission is presenting the promising results of two EU-funded international research projects which provide new hopes to help and treat people.

8 Apr 2011

GeoVax Labs to update its HIV/AIDS vaccine status at World Vaccine Conference

Harriet Robinson, Ph.D., Chief Scientific Officer at GeoVax Labs, Inc., will provide an update on the status of the Company's therapeutic and preventative HIV vaccines at the 2011 World Vaccine Conference at the Gaylord National Hotel and Convention Center in Washington DC on Thursday, April 14.

8 Apr 2011

Pharmaceutical News

Researchers discover new avenue for hypertension, cardiovascular disease treatment

Almirall strengthens its respiratory franchise with a new generation of Chronic Obstructive Pulmonary Disease (COPD) treatment

Immunization does not increase emergency room visit in children with inherited disorders

Florida Society of Pain Management Providers applauds Senate President for supporting PDMP

Scientists identify new treatment to combat PFAPA syndrome in children

IDSA, U.S. health officials describe ways to respond to global threat of antimicrobial resistance

Opinions: Budget talks, foreign aid; making drugs more accessible to poor

New weight loss pill - combination of two existing drugs

HealthWarehouse.com implements Google Commerce Search for prescription medications

Watson confirms patent challenge by Alcon for generic Vigamox

Impax, Banner Pharmacaps collaborate for commercialization of softgel capsule products

FDA accepts Antares Pharma's Anturol NDA for filing, assigns PDUFA date

Researchers test plants used in traditional African medicine against malaria

FluCide nanoviricide drug reduces overall leukocytes in lung tissue of influenza model

Lecture to explain science behind modern pharmaceutical products

Strathclyde establishes new EPSRC Centre to improve chemical manufacturing

How the pharmaceutical industry is confronting a changing landscape

Frailty in older patients not linked to high risk of adverse drug reactions

New substance to tackle drug resistant tuberculosis

GeoVax Labs to update its HIV/AIDS vaccine status at World Vaccine Conference

How industrial hygiene flow calibration supports defensible exposure data

How electrical engineering ensures accurate calibration and patient safety

The importance of ketones from a clinical and medical perspective

Latest News